Blood clotting plays an essential role in preventing excessive bleeding from injuries. When a blood vessel is damaged, platelets and proteins in plasma come together to form a clot, which eventually dissolves as the injury heals. However, blood clots can also occur internally, leading to significant health risks, such as deep vein thrombosis (DVT). DVT typically arises in deep veins, especially in the legs or arms, and can affect individuals of any age, including young athletes like NBA player Victor Wembanyama, who was recently diagnosed with the condition.
The Centers for Disease Control and Prevention estimates that approximately 900,000 people in the U.S. develop DVT annually. Factors contributing to DVT include both acquired and inherited risks, such as trauma, surgery, prolonged immobility, infections, and certain medications. The venous system relies on muscle movement to circulate blood; when movement is restricted, blood flow slows, increasing the likelihood of clot formation.
COVID-19 has been identified as a potential risk factor for DVT, as the virus can trigger inflammation and endothelial injury, leading to easier clot formation. Proactive measures, such as movement, awareness of symptoms (e.g., swelling, pain), and preventive anticoagulation, are crucial in reducing DVT risk.
Preventative strategies include regular exercise, wearing compression socks, and maintaining awareness of personal and family medical history concerning blood clotting issues. For individuals with symptoms suggestive of DVT, prompt medical evaluation is essential, as timely diagnosis and treatment can significantly improve outcomes. Blood thinners are commonly prescribed to dissolve clots, and in more severe cases, surgical intervention may be necessary.